Search Results - "Epstein RS"

Excess mortality attributable to hip fracture in White women aged 70 years and older.

Authors: Magaziner J Lydick E Hawkes W et al.

Source: American Journal of Public Health. Oct97, Vol. 87 Issue 10, p1630-1636. 7p.

Subjects: Death rate, Death, Older women, Pelvic fractures, Old age, Older people, Hip joint diseases

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

Authors: Epstein RS Moyer TP Aubert RE et al.

Source: Journal of the American College of Cardiology (JACC). Jun2010, Vol. 55 Issue 25, p2804-2812. 9p.

This result is not displayed to guests.
Login for full access.

From outcomes research to disease management: a guide for the perplexed.

Authors: Epstein RS Sherwood LM Epstein, R S et al.

Source: Annals of Internal Medicine. 5/01/96, Vol. 124 Issue 9, p832-837. 6p.

URL: 9605200372

Medication adherence: hope for improvement?

Authors: Epstein RS Epstein, Robert S

Source: Mayo Clinic Proceedings. Apr2011, Vol. 86 Issue 4, p268-270. 3p.

POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study.

Authors: Bridgewater, JA Hollebecque, A Furuse, J et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS218-S219. 2p.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Authors: Huskamp HA Deverka PA Epstein AM et al.

Source: New England Journal of Medicine. 12/4/2003, Vol. 349 Issue 23, p2224-2232. 9p.

Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial.

Authors: Salamone LM Cauley JA Black DM et al.

Source: American Journal of Clinical Nutrition. Jul99, Vol. 70 Issue 1, p97-103. 7p.

Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice.

Authors: Oster G Borok GM Menzin J et al.

Source: Archives of Internal Medicine. 4/8/96, Vol. 156 Issue 7, p731-739. 9p.

Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence.

Authors: Zeidan AM Zhao R Epstein RS et al.

Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2025 Nov; Vol. 25 (11), pp. 1243-1250. Date of Electronic Publication: 2025 Aug 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.

Authors: Zeidan AM Perepezko K Salimi T et al.

Source: Therapeutic advances in hematology [Ther Adv Hematol] 2024 Jul 30; Vol. 15, pp. 20406207241257313. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE

Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.

Authors: Zeidan AM Joshi N Kale H et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Sep; Vol. 22 (9), pp. 670-679. Date of Electronic Publication: 2022 Apr 22.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.

Authors: Harvey MJ Zhong Y Morris E et al.

Source: PloS one [PLoS One] 2022 Jan 24; Vol. 17 (1), pp. e0261336. Date of Electronic Publication: 2022 Jan 24 (Print Publication: 2022).

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.

Authors: Epstein RS Weerasinghe RK Parrish AS et al.

Source: Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 108-118.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

Abaloparatide Real-World Patient Experience Study.

Authors: Gold DT Weiss R Beckett T et al.

Source: JBMR plus [JBMR Plus] 2021 Feb 04; Vol. 5 (3), pp. e10457. Date of Electronic Publication: 2021 Feb 04 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101707013 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4039 (Electronic) Linking ISSN: 24734039 NLM ISO Abbreviation: JBMR Plus Subsets: PubMed not MEDLINE

Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.

Authors: Epstein RS Aapro MS Basu Roy UK et al.

Source: Advances in therapy [Adv Ther] 2020 Aug; Vol. 37 (8), pp. 3606-3618. Date of Electronic Publication: 2020 Jul 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther

Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.

Authors: Goyal L Meric-Bernstam F Hollebecque A et al.

Corporate Authors: Goyal L Meric-Bernstam F Hollebecque A et al.

Source: Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (36), pp. 2811-2822. Date of Electronic Publication: 2024 Jun 17.

Publication Type: Patient Education Handout

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Refractive outcomes among glaucoma patients undergoing phacoemulsification cataract extraction with and without Kahook Dual Blade goniotomy.

Authors: Sieck EG Capitena Young CE Epstein RS et al.

Source: Eye and vision (London, England) [Eye Vis (Lond)] 2019 Sep 19; Vol. 6, pp. 28. Date of Electronic Publication: 2019 Sep 19 (Print Publication: 2019).

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101664982 Publication Model: eCollection Cited Medium: Print ISSN: 2326-0254 (Print) Linking ISSN: 23260254 NLM ISO Abbreviation: Eye Vis (Lond) Subsets: PubMed not MEDLINE

Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.

Authors: Goyal L Meric-Bernstam F Hollebecque A et al.

Corporate Authors: Goyal L Meric-Bernstam F Hollebecque A et al.

Source: The New England journal of medicine [N Engl J Med] 2023 Jan 19; Vol. 388 (3), pp. 228-239.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER-medicare study.

Authors: Epstein RS Nelms J Moran D et al.

Source: Cancer treatment and research communications [Cancer Treat Res Commun] 2022; Vol. 31, pp. 100555. Date of Electronic Publication: 2022 Apr 04.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE